Criteo Reports Mixed Q4 Results, Issues Negative Q1 Guidance, and Boosts Share Buyback by $200M Amid Redomiciliation Plan
summarizeSummary
Criteo reported declining Q4 2025 results and issued negative Q1 2026 guidance, but significantly increased its share repurchase authorization by $200 million and confirmed the shareholder vote for its strategic redomiciliation to Luxembourg.
check_boxKey Events
-
Mixed Q4 2025 Financial Results
Q4 2025 revenue decreased 2% year-over-year to $541 million, net income fell 36% to $46 million, and diluted EPS dropped 27% to $0.90. Full-year 2025 results showed a 1% revenue increase and a 30% net income increase.
-
Negative Q1 2026 Guidance Issued
The company expects Q1 2026 Contribution ex-TAC to decline 11% to 9% year-over-year at constant currency, with Adjusted EBITDA between $50 million and $55 million, anticipating Q1 to be the low point of the year.
-
Share Repurchase Authorization Increased by $200M
The Board of Directors approved an increase in the share repurchase authorization by up to $200 million, following $152 million deployed in 2025. This significant authorization represents a substantial portion of the company's market cap.
-
Redomiciliation to Luxembourg Progressing
The Board approved the previously announced plan to redomicile to Luxembourg and directly list ordinary shares on Nasdaq, with a shareholder meeting scheduled for February 27, 2026, for approval.
auto_awesomeAnalysis
Criteo S.A. reported a mixed financial performance for Q4 2025, with key metrics like revenue, net income, and diluted EPS declining year-over-year. The company also provided a negative outlook for Q1 2026, expecting it to be the low point of the year due to previously communicated client scope changes. However, in a significant move, the Board of Directors increased the share repurchase authorization by up to $200 million. This substantial buyback, representing nearly 20% of the company's market capitalization and occurring while the stock trades near its 52-week low, signals strong management confidence in the company's valuation and future prospects. Additionally, the company confirmed the shareholder meeting date for February 27, 2026, to approve its strategic redomiciliation to Luxembourg and direct Nasdaq listing, a long-term initiative aimed at enhancing shareholder value.
At the time of this filing, CRTO was trading at $17.96 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $17.83 to $47.25. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.